[18A2-18A2];[18A3-18A3];
A set of isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Initial set of 519 isogenic deletions provides 56% genome coverage.
The current Exelixis collection at the Bloomington Stock Center differs from the original described in FBrf0175003 : a significant number were shown not to carry a deletion and have been removed from the collection; a number of stocks have been lost; a number of additional deletions are included that were generated after publication.
18A2;18A3
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion, confirmed by flanking sequence from the hybrid element associated with the deficiency, per R. Hoskins (BDGP).
Breakpoint location per R. Hoskins (BDGP), based on flanking sequence from the hybrid element associated with the deficiency.
Deletion has not been verified by complementation tests or tests for deleted sequences.